… business models amid rising generic competition for key drugs. As … and biotech stocks like Amgen, Inc. (AMGN). The Zacks Biomedical and … -profile drugs due to intensifying competition. Many big pharma… necessarily reflect those of Nasdaq, Inc.

… , Gilead Sciences Inc, Boehringer Ingelheim, Amgen Inc, GSK Plc, Sanofi and … medicines are now facing cheaper competition. Bristol said it would offer …

… nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim … available in this way include Amgen’s Repatha, for lowering cholesterol … arrival of low-cost generic competition would soon have prompted manufacturers …

… in the US Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim … number of factors, including the competition a treatment faces and insurance … taking the three priciest drugs; Amgen’s rheumatoid ‍arthritis treatment Enbrel …

… the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim … number of factors, including the competition a treatment faces and insurance …

… nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim … available in this way include Amgen's Repatha, for lowering … arrival of low-cost generic competition would soon have prompted manufacturers …

… companies named on Friday were Amgen, Boehringer Ingelheim, Bristol Myers Squibb … by the White House were Amgen’s cholesterol drug Repatha at … life, a point at which competition from generics would, in any …

… Genentech have struck deals. Novartis, Amgen, Boehringer Ingelheim, Sanofi and GSK … XR – set to face generic competition next year — directly to U … as part of its deal. Amgen said it will add migraine …

… ’s US unit Genentech. Novartis, Amgen, Boehringer Ingelheim, Sanofi, and GSK … are expected to face generic competition next year. If approved, Merck … Squibb, Gilead Sciences, Genentech, Novartis, Amgen, Sanofi, GSK, and Boehringer Ingelheim …

… in the US. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim … number of factors, including the competition a treatment faces and insurance …